Company Filing History:
3 out of 1,835 
1 out of 132 
1 out of 73 
Years Active: 2014-2018
Title: Herve Fridman: Innovator in Cancer Prognosis
Introduction
Herve Fridman is a notable inventor based in Paris, France. He has made significant contributions to the field of cancer research, particularly in developing methods for predicting patient survival times. With a total of 3 patents, Fridman's work is pivotal in enhancing cancer prognosis.
Latest Patents
Fridman's latest patents include innovative methods for predicting the survival time of patients suffering from solid cancers. One of his inventions focuses on determining the density of B cells at the invasive margin of tumors. This method involves comparing the density with a predetermined reference value to provide prognostic insights. Another patent offers methods and kits for assessing survival time based on the density of Th17 cells at various tumor locations. These advancements aim to improve the accuracy of cancer prognosis and patient care.
Career Highlights
Throughout his career, Fridman has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université Paris Descartes. His research has significantly impacted the understanding of cancer biology and patient outcomes.
Collaborations
Fridman has collaborated with notable colleagues, including Jerome Galon and Franck Pages. These partnerships have furthered his research and contributed to the development of innovative cancer prognosis methods.
Conclusion
Herve Fridman's contributions to cancer research through his patents and collaborations highlight his commitment to improving patient outcomes. His innovative methods for predicting survival times are essential advancements in the field of oncology.